XML 129 R115.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION Profitability (Details)
$ in Millions
12 Months Ended
Oct. 31, 2021
USD ($)
segment
numberOfCustomers
Oct. 31, 2020
USD ($)
numberOfCustomers
Oct. 31, 2019
USD ($)
numberOfCustomers
Segment Reporting [Abstract]      
Number of operating segments | segment 3    
Select income statement components      
Net revenue $ 6,319 $ 5,339 $ 5,163
Income from operations 1,347 846 941
Depreciation expense 122 119 111
Share-based compensation $ 110 $ 83 $ 72
Number of customers representing 10 percent or more of total net revenue | numberOfCustomers 0 0 0
Life Sciences and Applied Markets      
Select income statement components      
Net revenue $ 2,823 $ 2,392 $ 2,302
Income from operations 722 548 542
Depreciation expense 44 43 41
Share-based compensation 45 35 33
Diagnostics and Genomics      
Select income statement components      
Net revenue 1,296 1,047 1,021
Income from operations 273 192 185
Depreciation expense 39 39 35
Share-based compensation 22 17 14
Agilent CrossLab      
Select income statement components      
Net revenue 2,200 1,900 1,840
Income from operations 618 516 475
Depreciation expense 39 37 35
Share-based compensation 39 29 25
Segment Total      
Select income statement components      
Net revenue 6,319 5,339 5,163
Income from operations 1,613 1,256 1,202
Depreciation expense 122 119 111
Share-based compensation $ 106 $ 81 $ 72